Company News

Hansoh Pharma's IND Application for Two Class 1 Biological Innovative Drugs Accepted

2021.07.15 Size

Recently, the investigational new drug (IND) application for HS-20089 (for injection) and HS-20093 (for injection), two new Class 1 therapeutic biological products independently developed by Shanghai Hansoh BioMedical Co., Ltd. under Hansoh Pharma (3692.HK), was accepted and publicized by the National Medical Products Administration (NMPA)。

▲ Screenshot of public information from CDE, NMPA